dasatinib

Italy

Drugs containing this active substance

  • DARUPH

    It is used for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age. It is also indicated for Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) and for lymphoid blast crisis CML in adults who have not responded to other therapies.

    Form: tablets, film-coated

    Active substance Dosage
    dasatinib -

    ATC: L01EA02

    Manufacturer: ZENTIVA ITALIA S.R.L.

  • DASATINIB ACCORD HEALTHCARE

    It is used for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age, and for Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children at least 1 year of age. It is also indicated for lymphoid blast crisis CML in adults who have not benefited from previous therapies.

    Form: tablets, film-coated

    Active substance Dosage
    dasatinib -

    ATC: L01EA02

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • DASATINIB EG

    It is used for the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults who have not benefited from previous therapies.

    Form: tablets, film-coated

    Active substance Dosage
    dasatinib -

    ATC: L01EA02

    Manufacturer: EG S.P.A.

  • DASATINIB KRKA

    It is used for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age. It is also indicated for Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) and for CML in lymphoblastoid blast crisis in adults who have not benefited from other therapies.

    Form: tablets, film-coated

    Active substance Dosage
    dasatinib -

    ATC: L01XE06

    Manufacturer: KRKA D.D. NOVO MESTO

  • DASATINIB MYLAN

    It is used for the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) and chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age. It works by inhibiting the growth of leukemia cells.

    Form: tablets, film-coated

    Active substance Dosage
    dasatinib -

    ATC: L01EA02

    Manufacturer: MYLAN S.P.A.

  • DASATINIB SANDOZ

    It is used for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age. It is also indicated for Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) and for CML in blast crisis in patients who have not benefited from previous therapies.

    Form: tablets, film-coated

    Active substance Dosage
    dasatinib -

    ATC: L01EA02

    Manufacturer: SANDOZ S.P.A.

  • SPRYCEL

    It is used for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age, and acute lymphoblastic leukemia (ALL) with Philadelphia chromosome-positive (Ph+) in adults, adolescents, and children at least 1 year of age. It is also used for CML in lymph blast crisis in adults who have not responded to other therapies.

    Form: tablets, film-coated

    Active substance Dosage
    dasatinib -

    ATC: L01EA02

    Manufacturer: BRISTOL-MYERS SQUIBB PHARMA EEIG